Insider Trading - Azelby Robert

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Azelby Robert
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-02-12
Sale(A)
2018-02-15
7:31 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,159 $85.55 $355,802 89,612
(Direct)
View
2018-02-12
Sale
2018-02-14
7:24 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,157 $85.55 $355,631 89,614
(Direct)
View
2018-02-07
Sale
2018-02-09
7:27 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
3,497 $85.77 $299,938 222,318
(Direct)
View
2018-01-31
Sale
2018-02-02
7:26 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,167 $85.78 $357,445 189,765
(Direct)
View
2018-01-22
Sale
2018-01-24
6:46 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
102,539 $86.25 $8,843,989 168,293
(Direct)
View
2018-01-17
Sale
2018-01-19
9:00 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
29,131 $68.61 $1,998,603 202,876
(Direct)
View
2017-12-18
Sale
2017-12-20
4:37 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
1,816 $44.96 $81,647 70,832
(Direct)
View
2017-11-02
Sale
2017-11-03
7:30 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
6,666 $54.95 $366,297 106,666
(Direct)
View
2017-09-13
Sale
2017-09-14
7:31 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
12,850 $44.95 $577,608 37,439
(Direct)
View
2017-08-29
Sale
2017-08-31
7:44 pm
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
12,869 $39.95 $514,117 50,289
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-08-09
Ownership
2021-08-09
6:02 pm
N/A
2031-02-25
Eliem Therapeutics Inc. ELYM Azelby Robert
CEO
0 $0 1,190,462
(Direct)
View
2021-06-10
Option Award
2021-06-11
9:07 pm
N/A
2031-06-10
Clovis Oncology Inc. CLVS Azelby Robert
Director
42,223 $0 42,223
(Direct)
View
2020-10-23
Disposition
2020-10-23
5:34 pm
N/A
N/A
IMMUNOMEDICS INC IMMU Azelby Robert
Director
32,758 $0 0
(Direct)
View
2020-06-18
Option Award
2020-06-22
5:19 pm
2021-06-18
2030-06-18
IMMUNOMEDICS INC IMMU Azelby Robert
Director
10,258 $0 10,258
(Direct)
View
2020-06-04
Option Award
2020-06-05
4:55 pm
N/A
2030-06-04
Clovis Oncology Inc. CLVS Azelby Robert
Director
40,138 $0 40,138
(Direct)
View
2020-02-26
Option Award
2020-02-27
4:48 pm
2021-02-26
2027-02-26
IMMUNOMEDICS INC IMMU Azelby Robert
Director
22,500 $0 22,500
(Direct)
View
2019-10-22
Disposition
2019-10-24
6:52 pm
N/A
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
1,670,000 $0 0
(Direct)
View
2019-06-06
Option Award
2019-06-07
4:46 pm
N/A
2029-06-06
Clovis Oncology Inc. CLVS Azelby Robert
Director
28,882 $0 28,882
(Direct)
View
2019-04-23
Option Award
2019-04-25
6:56 pm
2019-04-23
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
150,000 $0 150,000
(Direct)
View
2019-02-06
Option Award
2019-02-08
4:40 pm
N/A
2029-02-05
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
520,000 $0 520,000
(Direct)
View
2018-10-11
Option Award
2018-10-15
6:44 pm
N/A
2028-10-11
Clovis Oncology Inc. CLVS Azelby Robert
Director
25,848 $0 25,848
(Direct)
View
2018-06-13
Option Award
2018-06-15
4:02 pm
N/A
2028-06-12
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
1,000,000 $0 1,000,000
(Direct)
View
2018-06-13
Ownership
2018-06-15
4:00 pm
N/A
N/A
ALDER BIOPHARMACEUTICALS INC ALDR Azelby Robert
CEO
0 $0 0
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
26,364 $0 0
(Direct)
View
2018-03-05
Disposition
2018-03-07
6:13 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
311,453 $0 0
(Direct)
View
2018-02-07
Tax Withholding
2018-02-09
7:27 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,700 $85.49 222,318
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,663 $20.76 222,318
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
834 $25.29 222,318
(Direct)
View
2018-02-07
Exercise
2018-02-09
7:27 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
3,497 $0 222,318
(Direct)
View
2018-01-31
Exercise
2018-02-02
7:26 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,167 $51.76 189,765
(Direct)
View
2018-01-31
Exercise
2018-02-02
7:26 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
4,167 $0 189,765
(Direct)
View
2018-01-31
Option Award
2018-02-02
7:26 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
25,639 $0 189,765
(Direct)
View
2018-01-22
Exercise
2018-01-24
6:46 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
102,539 $51.76 168,293
(Direct)
View
2018-01-22
Exercise
2018-01-24
6:46 pm
N/A
2025-10-31
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
102,539 $0 168,293
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
26,633 $20.76 202,876
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
2,498 $25.29 202,876
(Direct)
View
2018-01-17
Exercise
2018-01-19
9:00 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
29,131 $0 202,876
(Direct)
View
2017-11-08
Tax Withholding
2017-11-09
7:32 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
684 $55.98 72,648
(Direct)
View
2017-11-02
Exercise
2017-11-03
7:30 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
6,666 $25.29 106,666
(Direct)
View
2017-11-02
Exercise
2017-11-03
7:30 pm
N/A
2026-11-07
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
6,666 $0 106,666
(Direct)
View
2017-10-20
Option Award
2017-10-20
8:24 pm
N/A
N/A
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
35,893 $0 73,332
(Direct)
View
2017-06-09
Option Award
2017-06-13
4:37 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
13,927 $0 13,927
(Direct)
View
2017-04-03
Option Award
2017-04-04
5:43 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
12,437 $0 12,437
(Direct)
View
2017-03-31
Ownership
2017-04-04
5:40 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Azelby Robert
Director
0 $0 0
(Direct)
View
2017-02-07
Option Award
2017-02-09
7:31 pm
N/A
2027-02-06
Juno Therapeutics Inc. JUNO Azelby Robert
EVP & Chief Commercial Officer
155,280 $0 190,999
(Direct)
View
(A) Indicate amendment filing.